Canada Shifts Vaccine Injury Support to In-House Administration

Event summary

  • The Government of Canada is transitioning administration of the Vaccine Injury Assistance Program (VIAP) from Oxaro, Inc. effective April 1, 2026.
  • The program provides financial support to Canadians (excluding Quebec) who experienced serious, permanent injuries from Health Canada-authorized vaccines administered since December 8, 2020.
  • The transition aims to address a backlog of applications and improve transparency and consistency in the claims process.
  • Quebec will continue to administer its own Vaccine Injury Compensation Program.

The big picture

This shift represents a strategic move by the Canadian government to internalize a program previously outsourced to a third-party administrator. While the stated goals are improved efficiency and transparency, it also signals a potential reassessment of risk management and liability related to vaccine deployment. The move highlights the ongoing need for robust support systems for individuals experiencing adverse health events following public health interventions, a trend likely to be replicated in other jurisdictions.

What we're watching

Governance Dynamics
Bringing the program in-house suggests a desire for greater control over the process and potentially reduced costs, but could also expose PHAC to increased scrutiny and political pressure.
Regulatory Headwinds
The program’s evolution and future funding will likely be influenced by ongoing public perception of vaccine safety and the broader political climate surrounding vaccine mandates and public health interventions.
Execution Risk
The success of the VIAP hinges on PHAC’s ability to efficiently clear the existing backlog, implement the digital client portal, and maintain consistent, transparent claims processing – a significant operational challenge.

Related topics

Public Health